Replies to post #23884 on Lifeline Biotechnologies Inc (LLBO)

[Domains]

I agree Change. In addition, since a few days LLBO has $110,000 in cash and a $220,000 promissory note thanks to the sale of patents.

With that money, plus the investments and receivables stated in the Q1 filling, LLBO has enough money to pay the current $457,386 liabilities.

PR - http://www.marketwired.com/press-release/lifeline-biotechnologies-updates-pinksheets-llbo-2224617.htm
Q12017 - http://www.otcmarkets.com/financialReportViewer?symbol=LLBO&id=171880

For those who have panic to a possible reverse split, take into account that even if it happened, that won't be negative for the stock price. LLBO is the main investor in Cyrcadia with more than 45% of the shares. No further dilutions are needed for LLBO. A reverse split would simply reduce the number of outstanding shares, which would make LLBO even more attractive.

REVERSE SPLIT + DILUTION = NEGATIVE
REVERSE SPLIT + NO DILUTION = POSITIVE

The manipulators may be able to lower the price during the summer months, but they won't get many shares. People who haven't sold already, won't sell until iTbra is released in the US. No one will find a large number of shares below $0.004, which is the real value of LLBO based on its stake in Cyrcadia. The price will recover instantly after the summer.